Recent advances in bladder cancer diagnostics

Clinical Biochemistry

Volumn 37, Issue 7, 2004, Pages 562-571

  Sanchez Carbayo, Marta ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Bladder; Cancer; Carcinoma

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BCG VACCINE; GEMCITABINE; GENISTEIN; PACLITAXEL; TUMOR MARKER; VALRUBICIN;

BLADDER CANCER; CANCER DIAGNOSIS; CANCER MORTALITY; CYSTOSCOPY; DIAGNOSTIC ACCURACY; DNA MICROARRAY; HUMAN; MORBIDITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN MICROARRAY; PROTEOMICS; REVIEW; TRANSITIONAL CELL CARCINOMA; URINE CYTOLOGY;

BIOMEDICAL RESEARCH; CARCINOMA, TRANSITIONAL CELL; CYSTOSCOPY; GENE EXPRESSION PROFILING; GENE TARGETING; HUMANS; MODELS, BIOLOGICAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; SEQUENCE ANALYSIS, DNA; SEQUENCE ANALYSIS, PROTEIN; TRANSCRIPTION, GENETIC; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 3042640507     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2004.05.014     Document Type: Review

References (43)

1. Cancer facts and figures 2003. 2003;American Cancer Society. http://www.cancer.org/downloads/STT/CA2003pwsecured.pdf
2. Reuter V.E., Melamed M.R. The lower urinary tract. Sternberg S.S. Diagnostic surgical pathology. Third ed. 1999;1853-1891 Raven Press, New York
3. American Joint Committee on Cancer: Urinary Bladder Greene F.L. American Joint Committee on Cancer: cancer staging manual. Sixth ed. 2002;335-340 Springer-Verlag, New York
4. Lotan Y., Roehrborn C.G. Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses. Urology. 61:2003;109-118
5. Sanchez-Carbayo M. Use of high-throughput DNA microarrays to identify biomarkers for bladder cancer. Clin. Chem. 49:2003;23-31
6. Duggan D.J., Bittner M., Chen Y., et al. Expression profiling using cDNA microarrays. Nat. Genet. 21:1999;10-14
7. Hacia J.G., Collins F.S. Mutational analysis using oligonucleotide microarrays. J. Med. Genet. 36:1999;730-736
8. Fan J.B., Chen X., Halushka M.K., et al. Parallel genotyping of human SNPs using generic high-density oligonucleotide tag arrays. Genome Res. 10:2000;853-860
9. Iyer V.R., Horak C.E., Scafe C.S., et al. Genomic binding sites of the yeast cell-cycle transcription factors SBF and MBF. Nature. 25:2001;533-538
10. Pinkel D., Segraves R., Sudar D., et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat. Genet. 20:1998;207-211
11. MacBeath G., Schreiber S.L. Printing proteins as microarrays for high-throughput function determination. Science. 289:2000;1760-1763
12. Thykjaer T., Workman C., Kruhoffer M., et al. Identification of gene expression patterns in superficial and invasive human bladder cancer. Cancer Res. 61:2001;2492-2499
13. Sanchez-Carbayo M., Capodieci P., Cordon-Cardo C. Tumor suppressor role of KiSS-1 in bladder cancer: loss of KiSS-1 expression is associated with bladder cancer progression and clinical outcome. Am. J. Pathol. 162:2003;609-618
14. Dyrskjot L., Thykjaer T., Kruhoffer M., et al. Identifying distinct classes of bladder carcinoma using microarrays. Nat. Genet. 33:2003;90-96
15. Sanchez-Carbayo M., Socci N., Lozano J.J., et al. Gene identification in bladder cancer progression using cDNA microarrays. Am. J. Pathol. 163:2003;505-516
16. Kononen J., Bubendorf L., Kallioniemi A., et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med. 4:1998;844-847
17. Rao J., Seligson D., Visapaa H., et al. Tissue microarray analysis of cytoskeletal actin-associated biomarkers gelsolin and E-cadherin in urothelial carcinoma. Cancer. 95:2002;1247-1257
18. Espineda C., Seligson D.B., James Ball W. Jr., et al. Analysis of the Na, K-ATPase alpha- and beta-subunit expression profiles of bladder cancer using tissue microarrays. Cancer. 97:2003;1859-1868
19. Richter J., Wagner U., Kononen J., et al. High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer. Am. J. Pathol. 157:2000;787-794
20. Sanchez-Carbayo M., Socci N.D., Charytonowicz E., et al. Molecular profiling of bladder cancer using cDNA microarrays: defining histogenesis and biological phenotypes. Cancer Res. 62:2002;6973-6980
21. Chen C.C., Shieh B., Jin Y.T., et al. Microarray profiling of gene expression patterns in bladder tumor cells treated with genistein. J. Biomed. Sci. 8:2001;214-222
22. Liang G., Gonzales F.A., Jones P.A., et al. Analysis of gene induction in human fibroblasts and bladder cancer cells exposed to the methylation inhibitor 5-aza-2′-deoxycytidine. Cancer Res. 62:2002;961-966
23. Maxwell S.A., Davies G.E. Differential gene expression in p53-mediated apoptosis-resistant vs. apoptosis-sensitive tumor cell lines. Proc. Natl. Acad. Sci. U. S. A. 97:2000;13009-13014
24. Lu M., Wikman F., Orntoft T.F., et al. Impact of alterations affecting the p53 pathway in bladder cancer on clinical outcome, assessed by conventional and array-based methods. Clin. Cancer Res. 8:2002;171-179
25. Primdahl H., Wikman F.P., von der Maase H., et al. Allelic imbalances in human bladder cancer: genome-wide detection with high-density single-nucleotide polymorphism arrays. J. Natl. Cancer Inst. 94:2002;216-223
26. Hoque M.O., Lee C.C., Cairns P., et al. Genome-wide genetic characterization of bladder cancer: a comparison of high-density single-nucleotide polymorphism arrays and PCR-based microsatellite analysis. Cancer Res. 63:2003;2216-2222
27. Hoque M.O., Lee J., Begum S., et al. High-throughput molecular analysis of urine sediment for the detection of bladder cancer by high-density single-nucleotide polymorphism array. Cancer Res. 63:2003;5723-5726
28. Veltman J.A., Fridlyand J., Pejavar S., et al. Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. Cancer Res. 63:2003;2872-2880
29. Knezevic V., Leethanakul C., Bichsel V.E., et al. Proteomic profiling of the cancer microenvironment by antibody arrays. Proteomics. 1:2001;1271-1278
30. Reineke U., Volkmer-Engert R., Schneider-Mergener J. Applications of peptide arrays prepared by the SPOT-technology. Curr. Opin. Biotechnol. 12:2001;59-64
31. Haab B.B., Dunham M.J., Brown P.O. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol. 2:2001;1-4
32. Miller J.C., Zhou H., Kwekel J., et al. Antibody microarray profiling of human prostate cancer sera: antibody screening and identification of potential biomarkers. Proteomics. 3:2003;56-63
33. Schweitzer B., Roberts S., Grimwade B., et al. Multiplexed protein profiling on microarrays by rolling-circle amplification. Nat. Biotechnol. 20:2002;359-365
34. Robinson W.H., DiGennaro C., Hueber W., et al. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat. Med. 8:2002;295-301
35. Sanchez-Carbayo M, Socci ND, Lozano JJ, et al. Bladder cancer targeted antibody arrays for serum-based classification of patients with uroepithelial tumors (under review). We expect to be able to provide detailed information on this reference by proof revision.
36. Vlahou A., Schellhammer P.F., Mendrinos S., et al. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. Am. J. Pathol. 158:2001;1491-1502
37. Rasmussen H.H., Orntoft T.F., Wolf H., et al. Towards a comprehensive database of proteins from the urine of patients with bladder cancer. J. Urol. 155:1996;2113-2119
38. Ostergaard M., Wolf H., Orntoft T.F., et al. Psoriasin (S100A7): a putative urinary marker for the follow-up of patients with bladder squamous cell carcinomas. Electrophoresis. 20:1999;349-354
39. Celis J.E., Celis P., Ostergaard M., et al. Proteomics and immunohistochemistry define some of the steps involved in the squamous differentiation of the bladder transitional epithelium: a novel strategy for identifying metaplastic lesions. Cancer Res. 59:1999;3003-3009
40. Celis J.E., Celis P., Palsdottir H., et al. Proteomic strategies to reveal tumor heterogeneity among urothelial papillomas. Mol. Cell Proteomics. 1:2002;269-279
41. Kageyama S., Isono T., Iwaki H., et al. Identification by proteomic analysis of calreticulin as a marker for bladder cancer and evaluation of the diagnostic accuracy of its detection in urine. Clin. Chem. 50:2004;857-866
42. Orntoft T.F., Thykjaer T., Waldman F.M., et al. Genome-wide study of gene copy numbers, transcripts, and protein levels in pairs of non-invasive and invasive human transitional cell carcinomas. Mol. Cell Proteomics. 1:2002;37-45
43. Sanchez-Carbayo M., Saint F., Lozano J.J., et al. Comparison of the gene expression profiles of laser microdissected, OCT-embedded and non-embedded tumors. Clin. Chem. 49:2003;2096-2100